Use of natural extract of chestnut (Silvafeed ENC®) in broiler feeding: effect on growth performance

The aim of this research was to study the effect of addition of natural extract of chestnut (Castanea sativa) Silvafeed ENC® in commercial feed on the growth of broilers. Two hundred and four broiler chicks (Cobb 508) 14 d old male, were randomly assigned to 12 floor pens and fed commercial diet supplemented with 0% (CE0), 0.15% (CE15), 0.20% (CE20) and 0.25% (CE25) of ENC. The ENC addition showed a beneficial effect on weight increases daily feed intake (DFI) and average daily gain (ADG) from 14 to 35 days of age. In the second half of trial the effects were less evident and concluding with a detrimental effect in CE25 group. Feed conversion rate (FCR) appears to be statistically different in the second and fifth weeks of feeding. The inclusion of ENC at 0.20%, (CE20) had significant influences on final weight, DFI and ADG and a favourable influence on FCR in comparison with the other three groups. In conclusion, ENC has been shown to be beneficial at concentrations between 0.15% and 0.20%

Apparent digestibility of insect protein meals for rainbow trout

Insect meals are considered to be promising future ingredients for aquaculture feeds. In past feeding trials in rainbow trout, insect meals were included in diets only on the basis of their nutrients content and energy density without taking into account their biological availability due to the lack of their digestible values. Apparent digestibility (ADC) provides good indication of the bioavailability of nutrients and energy thus providing rational basis for the correct inclusion of feedstuffs. The aim of this research was to assess, in an in vivo trial on rainbow trout, the ADC of five full fat insect meals: one Tenebrio molitor (TM), two Hermetia illucens obtained through two different process (HI1 and HI2), one Musca domestica (MD), and one Alphitobius diaperinus (AD). Fish were fed a high-quality reference diet (R) and test diets obtained mixing the R diet with each of the test ingredients at a ratio of 70:30. Diets contained 1% celite as inert marker. Fish were fed to visual satiety twice a day and faecal samples collected using a continuous automatic device. Faeces were freeze dried and frozen (-20 \ub0C) until analyses. The ADC of dry matter, crude protein and ether extract of each insect meal diet were calculated. ADC for dry matter varied between 70.07 (HI1) and 80.85 (TM). ADC for protein was above 84% in all treatments and resulted the highest in MD, TM and AD treatments. Ether extract apparent digestibility significantly differed among diets with the highest value reported for TM treatment. All treatments reported values higher than 96%. Observed differences could be due to the insect species and meal treatment but in general, tested insect meals were highly digestible for rainbow trout. The results from this research could be useful to optimize the diet formulation

Effect of a Diet Supplemented with α-Tocopherol and β-Carotene on ATP and Antioxidant Levels after Hepatic Ischemia-Reperfusion

Ischemia-reperfusion injury associated with liver transplantation remains a serious complication in clinical practice. In the present study the effect of intake of α-tocopherol or β-carotene to limit liver injury by oxidative stress in ischemia and reperfusion was explored. Wistar rats were fed with diets enriched with α-tocopherol (20 mg/day) or β-carotene (3 mg/day) for 21 days. After 21 days, their livers were subjected to 15 and 30 min of ischemia and afterwards were reperfused for 60 min. The recovery of levels of ATP during reperfusion was better in the group of rats whose diets were supplemented with α-tocopherol or β-carotene than in the group control. The supplementation of the diet induced changes in the profile of enzymatic antioxidants. The supplementation with α-tocopherol and β-carotene resulted in a decreased of superoxide dismutase during the ischemia and a recovery was observed after reperfusion. Not changes were observed for the enzymes catalase and glutathione peroxidase and glutathione but their values were higher to those of the group control. In conclusion, the supplementation with α-tocopherol and β-carotene improve the antioxidant and energetic state of liver after ischemia and reperfusion injury

GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses.

Recombinant human growth hormone (GH) has been licensed for use in adult patients with GH deficiency (GHD) for over 15 years. Early weight- and surface area-based dosing regimens were effective but resulted in supraphysiological levels of insulin-like growth factor-I (IGF-I) and increased incidence of side effects. Current practice has moved towards individualized regimens, starting with low GH doses and gradually titrating the dose according to the level of serum IGF-I to achieve an optimal dose. Here we present the evidence supporting the dosing recommendations of current guidelines and consider factors affecting dose responsiveness and parameters of treatment response. The published data discussed here lend support for the use of low GH dosing regimens in adult GHD. The range of doses defined as 'low dose' in the studies discussed here (~1-4 mg/week) is in accordance with those recommended in current guidelines and encompasses the dose range recommended by product labels